New Key Statistics Module, Z-Score and F-Score
NAS:TARS Key Ratios
Market Cap $ M | 1,457.62 |
Enterprise Value $ M | 1,186.59 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 5.28 |
Price/Sales | 31.17 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 42.00 |
EPS (TTM) $ | -4.77 |
Beneish M-Score | 4.22 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -42.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -8.20 |
EV-to-EBITDA | -8.26 |
PEG | -- |
Shares Outstanding M | 37.78 |
Net Margin (%) | -348.22 |
Operating Margin % | -366.27 |
Pre-tax Margin (%) | -348.22 |
Quick Ratio | 7.92 |
Current Ratio | 8.01 |
ROA % (ttm) | -57.75 |
ROE % (ttm) | -73.59 |
ROIC % (ttm) | -2,076.98 |
Dividend Yield % | -- |
Altman Z-Score | 10.44 |
TARS Number of Guru Trades
TARS Volume of Guru Trades
Gurus Latest Trades with NAS:TARS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TARS is held by these investors
Total 1
Tarsus Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:TARS
Total 0- 1